Lobe Sciences Ltd

Lobe Sciences Ltd. (“Lobe Sciences”) (OTCPK:GTSIF) (CSE:LOBE) is currently operating in one of the hottest domains that is gaining importance particularly after the rising mental health problems in North America – psychedelic drugs. It is an IP-rich company that could become a true market leader in the mental health therapeutics sector over the coming years. As per Data Bridge Market Research, there is expected to be a strong rise in the prevalence of depression and anxiety-related mental ailments among Americans which is expected to give a huge impetus to the consumption of psychedelic drugs. The psychedelic pharma market is expected to triple in size in the coming 6 years at an annualized growth rate of 16.3% and Lobe Sciences is in an excellent position to capitalize on this market growth with its intellectual property assets.